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ORIGINAL ARTICLE


ABSTRACT
BACKGROUND: Completeness of excision is the most important factor influencing local recurrence after breast conserving surgery (BCS). The aim of this study was to determine factors influencing incomplete excision in patients undergoing BCS.
METHODS: A case control study was performed in 311 women with invasive breast cancer treated by BCS, of whom 193 had complete (CE) and 118 an incomplete excision (IE).  The maximum size of the cancer as measured microscopically was compared with the size as estimated prior to operation by mammography and ultrasound. A multivariable analysis was performed to investigate factors associated with incomplete excision.
RESULTS: Mammography underestimated tumour size in 75% of the IE group compared to 41% of the CE group (p<0.0001). Ultrasound underestimated tumour size in 83% of the IE group compared to 56% of the CE group (p<0.0001). The odds of an incomplete excision were greater when mammography or ultrasound underestimated pathological size OR=4.38; 95% CI 2.59, 7.41; p<0.001 for mammography and OR=3.64; 95% CI 2.03, 6,54; p<0.001 for ultrasound. For every 1mm underestimation of size by mammography and ultrasound, the relative risk of incomplete excision rose by 10% and 14% respectively. 
CONCLUSIONS: Underestimation of tumour size by current imaging techniques is a major factor associated with incomplete excision in women undergoing BCS. The presence of DCIS outwith the invasive cancer is largely responsible for the underestimation of total tumour size by imaging. 


INTRODUCTION
Breast conserving surgery (BCS) and postoperative whole breast radiotherapy is the preferred treatment for early breast cancer since it is as effective as mastectomy in terms of disease outcome and overall survival1. Moreover it has the benefits of superior cosmetic outcome, less psychological morbidity and improved self-esteem2. Not all patients are suitable for BCS and a number of factors influence patient selection. Tumour size must be balanced against overall breast volume. The single most important factor influencing the likelihood of local recurrence is completeness of excision: patients who have involved margins have an increased risk of local recurrence compared to those who do not3-17 even when they have adjuvant radiotherapy. Between 12 and 48% of patients who undergo BCS have involved margins and require re-excision10, 18-21.

Pre-operatively, tumour size is assessed routinely by mammography and ultrasonography, both of which are known to underestimate tumour size22-24. The Sloane Project, reviewed 2013 patients undergoing BCS for ductal carcinoma in situ (DCIS) and found that in 59% of patients requiring reoperation for involved margins pre-operative imaging underestimated extent of disease25. Although MRI better estimates tumour size26, it has not been shown in a randomised trial to increase rates of complete excision or to reduce local recurrence after BCS27, 28.  A previous study suggested that the risk of re-excision was greater if ultrasound underestimated tumour size but did not investigate this in detail29.

The hypothesis tested in the current study is that where imaging underestimates the actual size as assessed by the pathologist incomplete excision is more likely. The aim of this study was thus to determine whether imaging underestimation of tumour size was more frequent in cancers that were incompletely excised by BCS than those with complete excision after one operation. Furthermore, we hypothesised that the presence of an in situ component out with the invasive cancer increased the likelihood of imaging underestimation of tumour size and contributes to the rate of incomplete excision.


METHODS
This is a study of women diagnosed with invasive breast cancer and treated by breast conserving surgery (BCS) in the Edinburgh Breast Unit. All patients who had BCS between 1st June 2008 and 31st December 2009 were identified from South East of Scotland Breast Cancer prospectively collected database. All operations were performed by specialist breast surgeons and all wide local excisions were x-rayed intraoperatively and if the lesion approached any margin on the specimen x-ray further tissue was taken.  If invasive cancer or DCIS was within 1mm of a final radial (superior, inferior, medial or lateral) margin, including any further margin tissue taken after specimen x-ray then the excision was considered to be incomplete.  The rate of incomplete excision during this time for BCS was 18.75%. Patients who had neoadjuvant chemotherapy or neoadjuvant hormonal therapy were excluded. To improve the statistical power a case control study was performed where the population under investigation (i.e. the incomplete excision patients) were examined in a greater proportion (2:1) than they would be in the normal population. Thus, together with all the incomplete excision patients, just over half of the complete excision patients were chosen in order to enrich the population for incomplete excision patients.  This provided a group of 316 patients (all of whom were women) of whom 5 were excluded because of imaging at private hospital (n=1), missing notes (n=3), cancer diagnosed incidentally at excision of axillary hidradenitis suppurativa with no pre-operative imaging (n=1). Of the 311 remaining women 193 (62%) had complete excision (CE) and 118 (38%) had incomplete excision (IE) respectively. All 311 women had both mammography and ultrasound performed and these were reported by specialist breast radiologists in a standard manner.  Of the 311 women, 289 had data available for ultrasound tumour size and 290 had mammography size with 276 having both. Some cancers were not well seen by either mammography or ultrasound and so had no measurement of maximum tumour size recorded resulting in missing imaging size estimates. There were no missing size estimates from the cancers that were visible on ultrasound or mammogram. Three hundred and three (303) women had at least one imaging modality tumour size measurement recorded prior to surgery. 
 Data for patient and tumour variables collected from each patient are shown in Table 1. All data were retrieved from the cancer database, patient notes, imaging reports and pathology records. All patients suspected of having breast cancer had both mammography (conventional film or digital) and ultrasound prior to surgery. Tumours were measured in 3 dimensions and data were recorded prospectively and the size used in this study was the largest diameter including any visible DCIS. 
The Edinburgh breast pathology department follows the National Breast Reporting Guidelines30. Both the largest diameter of the invasive component and the largest diameter of the tumour including any in situ disease are recorded. The difference between these two values gives a measurement of how much the whole tumour size is increased by in situ carcinoma out with the invasive component. This has been termed the “in situ component” for the purpose of this study. The pathological measurement used for this study was the largest diameter reported by the pathologist and includes that of both the primary excision and any additional disease found at subsequent re-excision or mastectomy. The distance between the tumour and the excision margin was assessed by specialist breast pathologists, and excision on the initial wide excision specimen was considered as incomplete when either invasive or in situ carcinoma was present within 1mm from the inked edge of any radial margin. As almost all true local recurrences in breast tissue are related to positive radial margins, anterior and posterior margins were not re-excised even if disease was <1mm if full thickness of breast tissue had been excised. The current practice in Edinburgh during the study was thus to consider excision incomplete if a radial margin was <1mm. 
Statistical Analysis
Data were analysed using SPSS software (IBM Corp. Released 2010. IBM SPSS Statistics for Windows, Version 19.0. Armonk, NY: IBM Corp.). Bland-Altman plots were used to assess the extent of agreement between radiological and pathological sizes. The differences between the paired values were plotted against the mean of the values. The mean of the difference gives a measure of bias of one technique over the other. Where it was possible to compare the data in a 2x2 table, odds ratios were calculated directly using the Mantel-Haenszel method for p-values and confidence intervals. The association between imaging underestimation of tumour size and each independent patient and disease characteristic was tested using logistic regression. This technique was also used to test the relationship between complete/incomplete excision and the independent variables. For continuous variables such as size, then the variable was examined as a continuous as well as a categorical one. A P-value <0.05 was deemed significant. The aim of this study was to identify what factors were significantly related to an incomplete excision (table 1).
Each variable was examined against the outcome (CE vs IE) both on its own (univariately) and as part of a multi-variable model (multiple explanatory variables). The modelling was performed using a backwards elimination technique, executed manually due to the number of missing values, by removing one variable at a time from the data and examining the effect of each. The variable that contributed the least to the model was removed and the process begun again. Traditional methods of automated model selection only include patients with complete data for all the variables entered into the model to be tested, so with missing data and large numbers of variables of interest, the number of patients available for analysis falls very quickly. Manual execution of the technique allows for improved control over the amount of data available in each model iteration. Hazard ratios were calculated from Cox survival models by holding the time to event to be 1 for all patients, with status as complete/incomplete excision. Relative risks (from categorical explanatory variables) were calculated by comparing each level with the reference level, excluding any intervening levels. 
RESULTS
The mean ages for the CE and IE groups were 61.08 years and 59.42 years respectively, with no significant difference between these (t-test; p<0.15). 
Factors that were associated with incomplete excision on the univariate analysis were difference between pathological size and both mammographic and ultrasound size (both p<0.001), extent of DCIS outwith the invasive cancer (p<0.001), multifocality (P<0.001), lymphatic vascular invasion (p=0.012) and final pathology size including both invasive cancer and DCIS (p<0.001).
Extent of agreement between imaging and pathological size
The extent of radiological underestimation of pathological size measurements in both the CE and IE groups is presented in Table 2. Also provided in this table are the numbers and percentage where radiology underestimated pathology size by more than 5mm. Both mammography and ultrasound produced a significant, non-systematic bias in the IE group (p<0.001), such that the bias is not related to the size of the difference. In the CE group there was closer association between the imaging and pathological sizes (USS Pearson’s rho = 0.78 p<0.001; Mammogram Pearson’s rho = 0.72, p < 0.001) compared with the IE group (USS Spearman’s rho = 0.55 p<0.001; Mammogram Spearman’s rho = 0.30, p = 0.002). In a significantly higher number of patients, imaging underestimated pathological size in the incomplete excision group (USS: 83% vs 56%, p<0.0001; Mammogram: 75% vs 41%, p<0.0001, for IE vs CE respectively). If one considers a margin of error of 5mm, there were still significantly greater numbers of patients with underestimation of pathological size in the incomplete excision group compared with the complete excision group. (USS: 77% vs 31%, p<0.0001; Mammogram: 62% vs 19%, p<0.0001).

The risk of an incomplete excision was over four times greater when the mammography estimate of tumour size was smaller than the pathological size (OR=4.38; 95% CI 2.59, 7.41; p<0.001). The odds of an incomplete excision was increased just over three-fold when the ultrasound measurement was less than the pathological size (OR=3.64; 95% CI 2.03, 6,54; p<0.001). Figures 1 and 2 show the relative risk of an incomplete excision with varying differences between imaging and final pathology size, and demonstrate that the larger the difference between imaging and pathological size the greater the risk of incomplete excision.  The risk of incomplete excision was greatest when both ultrasound and mammography underestimated tumour size (OR=4.66; 95% CI 2.72, 7.99; p<0.001). 

The mean underestimate of size for mammography of total tumour size was 4.26mm and 7.34mm for USS. However, for incomplete excision cases, this was 11.69mm and 17.18mm respectively. In comparison, in the complete excision cases mammography overestimated the pathological size by an average of 0.15mm, although USS still underestimated tumour size by an average of 1.89mm. These differences (CE vs IE) were significant for both imaging methods (p<0.0001).

By logistic regression, for every 1mm of underestimation of pathology size by  mammography, the risk of incomplete excision increased by an OR of 1.10; (95% CI 1.06-1.14); p<0.001. Likewise, for every 1mm underestimation of pathology size by ultrasound, the risk of incomplete excision increased by an OR of 1.14, (95% CI 1.10-1.19), p<0.001.
To determine what other factors influenced completeness of excision, a best fit model was applied to the clinical and pathological variables listed in Table 1 or Table 2. 307 patients were available for this model; 4 patients could not be included due to missing data. For every 1mm increase in the maximum diameter of the tumour by in situ cancer, the odds of an incomplete excision increased by 14% (OR=1.14, 95% CI 1.10, 1.18; p<0.001). For patients with any in situ component outside the invasive cancer, the odds of an incomplete excision were twice as high as that of a patient without a DCIS component (OR=2.16, 95% CI 1.16, 4.02; p=0.015). The presence of multifocal disease conferred a five-fold increase in the risk of incomplete excision compared to patients with unifocal disease (OR=5.29, 85% CI 2.10, 13.33; p<0.001). None of the other variables listed in table 1 had a statistical association with incomplete excision in the multivariable analysis.
The difference between pathological size and radiological size was added to the model containing the significant clinical variables, and underestimation by mammography was a significant contributor to the model (OR=2.47, 95% CI 1.21, 5.03; p=0.013). 
The influence of in situ cancer outwith the invasive cancer
Mammography
The mean extent of the in situ component for cancers where mammography underestimated pathology size was over four times greater than that of tumours that were not underestimated by mammography (t-test; p<0.001).
Ultrasound
Likewise, the mean size of the in situ component for cancers whose size was underestimated by ultrasonography was over eight times greater than that of the tumours that were not underestimated by ultrasonography (t-test; p<0.001)
The risk of an incomplete excision was over four times greater when the in situ component of a tumour increased the overall tumour size beyond that of the maximum diameter of the invasive component (OR=4.46; 95% CI 2.72, 7.33; p<0.001). 
DCIS Component
The percentage of incomplete excisions increased as the size of the in situ component increased (χ2 test for trend; p<0.001). Grade of DCIS was important with an odds ratio of 2.32 (95% CI 1.41 - 38.4, P=0.01) for high grade DCIS vs low and intermediate grade DCIS. Only the presence of DCIS outwith the cancer was significant (OR 3.79, 95% CI 2.23 – 6.43 P<0.001) and there was no significant effect of DCIS within the primary cancer (OR 1.48 95% CI 0.84- 2.60 P=0.23). 
If the size of the in situ component outwith the main cancer mass is analysed as a continuous variable, then for every 1mm increase in size from DCIS, the risk of an incomplete excision rises by an OR of 1.12; 95% CI 1.07, 1.17; p<0.001). Where the DCIS component was absent or was within the invasive tumour there was a significantly lower rate of incomplete excisions compared with those with DCIS outwith the invasive cancer (OR=4.5 95% CI 2.7, 7.3; p<0.001). 
Best Fit Model Predicting Incomplete Excision
The model that best predicts for incomplete excision includes the maximum diameter of the tumour including DCIS, multifocal disease and the difference in size between ultrasound and final pathology. 82% of excisions, whether complete or incomplete, can be predicted based on these features of the primary cancer. All are histological features and none are available prior to excision. 

DISCUSSION
This is the first study to investigate in detail the influence of radiological underestimation of tumour size on completeness of excision of invasive breast cancers undergoing BCS. It is known that current imaging techniques underestimate whole maximum tumour size22-24, 26-29. The mean underestimation in this study was much greater in patients who had incomplete excisions and in this group was 11.7mm for mammography and 17.2mm for ultrasonography. Other studies have shown a wide variation of size underestimation but most have demonstrated slightly better estimates with ultrasound compared with mammography22-24, 26-29. In contrast to mammography, ultrasound is relatively poor at visualising in situ disease whereas microcalcifications can be seen on mammograms and are often an indicator of the presence of DCIS. In this study, 69% of all patients had some DCIS associated with their invasive cancer and ultrasound may not have visualised this DCIS out with the invasive cancer. The estimated size of the cancer on ultrasound did include any “hyperechoic halo” which might include some of any surrounding DCIS. The odds of an incomplete excision were trebled when ultrasound underestimated the tumour size, while mammographic underestimation quadrupled the risk. When both mammography and ultrasound underestimated tumour size, the risk of incomplete excision was also increased more than four-fold. Whereas one other study has shown radiological underestimation of total tumour size influences the rate of incomplete excisions29, the current study shows that as the difference between the imaging size and final pathology size increases so does the rate of incomplete excisions. 
When examining a ‘best fit’ model of factors that influence completeness of excision, of the two imaging techniques, underestimation by ultrasound significantly increased the risk of incomplete excision. Ultrasound is recognised to be poor at visualising DCIS31 and this is illustrated by our findings that for every 1mm increase in the size of the in situ component, there was a 19% increase in the risk that ultrasound would underestimate tumour size. A large in situ component outwith the invasive cancer was also found to be associated with incomplete excision of the tumour. For every 1mm increase in the size of the in situ component, the risk of incomplete excision rose by 12%. 

Tumour size is an important prognostic indicator for breast cancer32, and is thus, a critical variable in staging systems and a key factor in deciding treatment strategy. The surgeon relies on the radiological estimate to guide resection of the tumour. Previous studies have shown the benefit of wire-localisation techniques in BCS33-36, however, whether the cancer was localised prior to operation made no significant difference to the completeness of excision in our model. Factors associated with incomplete excision included the presence of multifocal disease. Multifocal disease which is often unrecognised prior to surgery is known to be associated with an increased rate of incomplete excision and of local recurrence29. 
The inadequacy of current radiological investigations to estimate tumour size has led to the exploration of several pre-operative and intraoperative techniques either to estimate the extent of disease or to ensure excision of the imaged and occult disease. Studies have shown that MRI increases the detection of occult foci of disease in breast cancer patients3, 27, 29, 37, 38. However, a recent meta-analysis of 12 observational studies examining the effectiveness of pre-operative MRI in the assessment of early breast cancer reported that in 11.3%, MRI led to more extensive surgery than initially planned but did not improve surgical treatment or outcomes37. In the COMICE randomised-controlled trial there was no difference in the re-operation rate between groups assigned to MRI (n=816) or no further imaging (n=807)27, 28. COMICE did show that the weight of tissue excised was greater in the MRI group, so more tissue was removed as a consequence of the MRI findings, but this did not benefit the patient in terms of either completeness of excision or short term recurrence rates. Other studies evaluating MRI have failed to reach consensus on the value of MRI in women having breast conserving surgery39, 40. Currently the routine use of pre-operative MRI is not warranted and it should be reserved for specific clinical situations where other imaging modalities are unreliable or inconclusive.  

Several small studies have demonstrated the benefits of utilising intraoperative ultrasound for guiding the excision of both non-palpable and palpable breast cancers41-45. Advantages claimed for intraoperative ultrasound include improved margin clearance, reduced need for re-excision and better lumpectomy specificity. The technique has been reported to reduce the rate of involved margins to 3-10%41-45. While ultrasound performed by the surgeon during operation allows for greater surgical autonomy and obviates the need for radiologist led tumour localisation, it is greatly dependent on the training and experience of the surgeon. The likelihood that intraoperative ultrasound will increase excision rates is unlikely as our observation is that a major reason surgeons fail to completely excise a cancer is that disease is present that is not visible on imaging and that includes ultrasound. An alternative is to use other methods of intraoperative margin assessment to identify the presence of in situ and invasive cancer close to the margins. Such devices use different methodologies including delivering radiofrequency into the margin and capturing reflected signals or bioimpedance spectroscopy that is very sensitive to extracellular and intracellular variations in dielectric tissue properties46, 47.  Results have been encouraging to date46, 47 but the studies completed thus far have significant limitations. Further studies of the cost effectiveness of such an approach are needed and are ongoing.
One limitation of this study is that patients were drawn from a single centre, and the patient characteristics and treatment protocols may not be representative of those in other centres. The study was also reliant on the accuracy of medical records and the SCAN database for important variables, particularly demographic data. However, all measurements were performed prospectively and cross referenced between patient notes and the database.  The groups were not case matched and it is difficult to control for confounders, but the associations found in this study seem logical and are likely to be correct. 
This retrospective study has shown the inaccuracy of current pre-operative imaging techniques for estimating the size of invasive breast cancers. Our results demonstrate that a radiological underestimation of tumour size is a major factor in incomplete excision. We have shown that the rate of radiological underestimation and incomplete excision increases as the size of the in situ component of a tumour increases. It is the presence of in situ cancer outwith the invasive cancer component that is a major reason why breast cancers are so commonly incompletely excised. Over 80% of incomplete excisions can be explained by histological features of the breast cancer, and a major factor is disease that is present but not seen by imaging and presumably therefore, cannot be palpated by the surgeon and is occult.  The current study showed that in our Unit incomplete excision rates are greatly influenced by the histological features of the cancers, rather than the surgeon. A large study of DCIS however demonstrated that a major reason for the variation in rates of margin failure between different units was due to differences in practice in various units and not patient or pathology factors48. The strength of the current paper is that it was performed in a single unit with a consistent practice and in our unit pathology factors were the major determinant of incomplete excision. Since performing this study there has been debate on what constitutes an adequate margin of excision.  In this study we used a 1mm radial margin and two meta-analyses support this3, 49, but it may be that no ink on tumour is sufficient.  Had we used a definition of no ink on tumour it is unlikely to have changed our findings or our conclusions.  
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Table 1. Clinical and pathological variables collected for each patient

Clinical Variables	Pathological Variables
Age at diagnosisMenopausal statusDensity of breast tissueSmoking historyHRT historyParityMode of presentationPalpability of tumourMaximum tumour diameter on mammographyTumour dimensions on mammographyMaximum tumour diameter on USSTumour dimensions on USSTumour stage (1-4)N stage (0-1)Number of nodes examinedNumber of nodes involvedType of BCSSurgeon	Tumour dimensionsMaximum diameter of the invasive componentMaximum tumour diameter including CISDistance to the excision marginDistribution of CIS out with or within the invasive componentTumour typeTumour shapePresence of multifocalityER statusPR statusHER-2 statusPresence of lymphovascular invasionPresence and type of calcificationHighest DCIS grade DCIS growth patternComedo necrosis




Table 2: Number of cases with radiological underestimation, both in absolute terms and with an ‘acceptable’ difference 5mm 
	

	Complete excision	Incomplete excision
Radiology smaller than path		
Mammography (n=290)	74/182 (41%)	81/108 (75%)
Ultrasound (n=289)	105/186 (56%)	85/103 (83%)
Both Mammo & USS (n=276)	64/179 (36%)	70/97 (72%)
		
		
Radiology more than 5mm smaller than path		
Mammography (n=290)	27/182 (15%)	60/108 (56%)
USS (n=289)	33/186 (18%)	71/103 (69%)
Both Mammo & USS (n=276)	17/179 (9%)	51/97 (53%)


Figure 1. Relative risk of incomplete excision for differences in mm between the pathological size and mammographic estimations of size. 



Figure 2. Relative risk of an incomplete excision for differences in mm between the pathologic size and ultrasound estimation of size. 
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